Pancreatic Cancer: Research-driven Clinical Progress Examined at AACR Special Conference
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed by patients and their families. At present, increasingly complex chemotherapy regimens offer only marginal improvements...